INHIBITORY AND REGULATORY BINDING-SITES ON THE RAT-BRAIN SEROTONIN TRANSPORTER - MOLECULAR-WEIGHT OF THE [H-3] PAROXETINE AND [H-3] CITALOPRAM BINDING-PROTEINS

被引:42
|
作者
PLENGE, P
MELLERUP, ET
NIELSEN, M
机构
[1] RIGSHOSP,INST PSYCHOCHEM,DK-2100 COPENHAGEN,DENMARK
[2] SCI HANS HOSP,DEPT E,PSYCHOPHARMACOL RES LAB,DK-4400 ROSKILDE,DENMARK
关键词
H-3]PAROXETINE; H-3]CITALOPRAM; 5-HYDROXYTRYPTAMINE (5-HT) TRANSPORT COMPLEX; RECEPTOR MODULATION; BRAIN (RAT);
D O I
10.1016/0922-4106(90)90016-Q
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Citalopram binds with high affinity to a specific binding site located on the serotonin (5-HT) transporter in 5-HT neurons. The binding affinity of [H-3]citalopram was found to increase with increasing concentration of citalopram. This may be a homotropic positive allosteric effect, thus indicating the presence of an allosteric binding site for citalopram. The molecular weight of the proteins containing the high-affinity binding sites for citalopram and paroxetine, as well as the allosteric binding site for citalopram were determined by the irradiation method. The molecular weights of the three binding site proteins were found to be the same, suggesting that all three binding sites are located on the same protein molecule in the 5-HT transporter. The results support a hypothesis that the binding area for [H-3]citalopram is located deeper in the transport channel than the [H-3]paroxetine binding area. Thus the two high-affinity binding sites probably cover different, but overlapping, parts of the protein molecule. The allosteric binding site may be located elsewhere on the protein where it induces conformational changes of the 5-HT transporter with the result that high-affinity bound ligands get trapped in the transport channel, thereby explaining the increase in affinity.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 50 条
  • [41] MIGRAINE AND SEROTONIN UPTAKE, H-3 PAROXETINE AND H-3 IMIPRAMINE BINDING
    COTRIM, MD
    RIBEIRO, CAF
    MACEDO, TRA
    DIOGO, L
    SALES, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1917 - 1917
  • [42] AUTORADIOGRAPHY OF ANTIDEPRESSANT BINDING-SITES IN THE HUMAN-BRAIN - LOCALIZATION USING [H-3]IMIPRAMINE AND [H-3] PAROXETINE
    CORTES, R
    SORIANO, E
    PAZOS, A
    PROBST, A
    PALACIOS, JM
    NEUROSCIENCE, 1988, 27 (02) : 473 - 496
  • [44] SOLUBILIZATION AND CHARACTERIZATION OF [H-3] IMIPRAMINE AND [H-3] PAROXETINE BINDING-SITES FROM CALF STRIATUM
    ROTONDO, A
    GIANNACCINI, G
    QUATTRONE, C
    MARAZZITI, D
    MARTINI, C
    CASSANO, GB
    LUCACCHINI, A
    NEUROCHEMICAL RESEARCH, 1994, 19 (10) : 1295 - 1300
  • [45] SELECTIVE LABELING OF SEROTONIN UPTAKE SITES IN RAT-BRAIN BY [H-3] CITALOPRAM CONTRASTED TO LABELING OF MULTIPLE SITES BY [H-3] IMIPRAMINE
    DAMATO, RJ
    LARGENT, BL
    SNOWMAN, AM
    SNYDER, SH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 242 (01): : 364 - 371
  • [46] Comparison of [H-3]paroxetine and [H-3]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain
    Gurevich, EV
    Joyce, JN
    NEUROPSYCHOPHARMACOLOGY, 1996, 14 (05) : 309 - 323
  • [47] [H-3]GLUTAMATE BINDING IN RAT-BRAIN
    TSUJIMURA, R
    OTA, M
    NOMURA, J
    HATOTANI, N
    NEUROCHEMICAL RESEARCH, 1983, 8 (06) : 775 - 776
  • [48] DIFFERENTIAL INTERACTIONS OF MUSCARINIC DRUGS WITH BINDING-SITES OF [H-3] PIRENZEPINE AND [H-3] QUINUCLIDINYL BENZILATE IN RAT-BRAIN TISSUE
    TONNAER, JADM
    VANVUGT, MA
    DEBOER, T
    DEGRAAF, JS
    LIFE SCIENCES, 1987, 40 (20) : 1981 - 1987
  • [49] [H-3] ZONISAMIDE BINDING IN RAT-BRAIN
    MIMAKI, T
    SUZUKI, Y
    TAGAWA, T
    TANAKA, J
    ITOH, N
    YABUUCHI, H
    JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY, 1988, 42 (03): : 640 - 642
  • [50] CHARACTERIZATION OF BINDING-SITES FOR SPIDER TOXIN, [H-3] NSTX-3, IN THE RAT-BRAIN
    INO, H
    NAKADE, S
    NIINOBE, M
    IKENAKA, K
    TESHIMA, T
    WAKAMIYA, T
    MATSUMOTO, T
    SHIBA, T
    KAWAI, N
    MIKOSHIBA, K
    NEUROSCIENCE RESEARCH, 1990, 8 (01) : 29 - 39